Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

SALT LAKE CITY, June 03, 2024 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College...

Related Keywords

San Antonio ,Texas ,United States ,Dale Muzzey ,Allison Kurian ,Glenn Farrell ,Matt Scalo ,Exchange Commission ,Stanford University School Of Medicine ,American College Of Medical Genetics ,Genetics Inc ,Nasdaq ,American College ,Medical Genetics ,Hereditary Cancer ,Spotlight Presentation ,Antonio Breast Cancer Symposium ,Myrisk Hereditary Cancer Test ,Stanford University School ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,